Generics gain indications for glycemic control, reducing heart failure hospitalization ...

I have been a clinical researcher for almost 50 years. After medical school and internal medicine residency, I was selected to go to the National Institutes of Health where I learned the basics of ...

Bipartisan lawmakers have revived efforts to require Medicare to cover generic drugs — and at least two biosimilars — with patients paying lower costs than for brand-name drugs, POLITICO’s Alec Snyder ...

The Association for Accessible Medicines’ annual U.S. Generic & Biosimilar Medicines Savings Report, in partnership with the IQVIA Institute, reveals that the use of Food and Drug Administration ...

Replacing high-cost generics with cheaper medications that have the same clinical benefit could have cut down spending and saved patients about 88%, according to Johns Hopkins research published in ...

ANIP eyes 2026 growth via Cortrophin's gout push and steady generics launches, as Rare Disease expansion reshapes priorities and investor focus.

Cheap semaglutide generics have launched in India following local loss of exclusivity for Novo Nordisk, triggering rapid price cuts and market share shifts in GLP-1 treatments. Dozens of low cost ...

Manufacturers of generic and biosimilar medicines should rethink their real world launch, lifecycle and litigation strategies ...

Axelpharm, the Russian manufacturer of anticancer generics, may suspend operations due to fines from the local antitrust ...